Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended On June 30 2025 And To Transact Other Businesses.
News Announcement

Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended On June 30 2025 And To Transact Other Businesses.

02-Aug-2025 Follow Value Research Online on Google download pdfDownload PDF Aspira Pathlab

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) along with Limited Review Report for the first quarter ended on June 30 2025 and to transact other businesses.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds